Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProQR Therapeutics N.V. - Ordinary Shares (NQ:PRQR)

1.650 -0.020 (-1.20%)
Delayed Quote Updated: 3:08 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProQR Therapeutics N.V. - Ordinary Shares

< Previous 1 2 3 4 5 Next >
News headline image
Tesla To $175? Here Are 10 Other Price Target Changes For Friday ↗
Oppenheimer cut CarMax, Inc. (NYSE: KMX) price target from $100 to $75. . Oppenheimer analyst Brian Nagel maintained an Outperform rating on the stock. CarMax shares fell 1.3% to $56.47 in pre-market... 
Via Benzinga
News headline image
Dow Dips 600 Points; AMC Entertainment Shares Plunge ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 600 points on Thursday. 
Via Benzinga
News headline image
SKLZ Stock Alert: Will Skillz Shares Get Delisted? ↗
Skillz (SKLZ) stock is worth checking on today as the company received a delisting notice from the New York Stock Exchange. 
Via InvestorPlace
News headline image
Why Are Chinese EV Stocks NIO, XPEV, LI on Watch Today? ↗
Chinese electric vehicle (EV) stocks are a chief concern among investors today as these shares see mixed trading on Thursday! 
Via InvestorPlace
News headline image
Why Is ProQR (PRQR) Stock Up 83% Today? ↗
ProQR (PRQR) stock is rising on Thursday thanks to an expanded licensing and collaboration agreement with Eli Lilly (LLY). 
Via InvestorPlace
News headline image
Raymond James Bullish On This Penny Stock's Reprioritized Pipeline ↗
 
Via Benzinga
News headline image
This Penny Stock Biotech Offloads Eye Portfolio To Focus On RNA-Editing ↗
 
Via Benzinga
News headline image
Expert Ratings for ProQR Therapeutics ↗
Within the last quarter, ProQR Therapeutics (NASDAQ:PRQR) has observed the following analyst ratings: 
Via Benzinga
News headline image
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
News headline image
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher ↗
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 600 points on Thursday. 
Via Benzinga
News headline image
Where ProQR Therapeutics Stands With Analysts ↗
Analysts have provided the following ratings for ProQR Therapeutics (NASDAQ:PRQR) within the last quarter: 
Via Benzinga
News headline image
ProQR Therapeutics Pulls Plug On Inherited Retinal Disease Programs, Cuts 30% Workforce ↗
 
Via Benzinga
News headline image
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3 ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping over 300 points on Thursday. 
Via Benzinga
News headline image
ProQR Therapeutics Shares Soar As Eli Lilly Expands RNA Collaboration ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Thursday! 
Via InvestorPlace
News headline image
ProQR Announces Conference Call to Discuss Axiomer® RNA Editing Platform
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Lilly and ProQR to Expand RNA Editing Collaboration
New agreement supports the discovery and development of additional assets directed toward high conviction targets utilizing ProQR’s Axiomer technology 
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR to Present its Axiomer® RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES Europe) 2022
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Third Quarter 2022 Operating and Financial Results
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
ProQR Announces Webcast of Presentation at the Upcoming Stifel 2022 Healthcare Conference
From ProQR Therapeutics N.V.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗
  
Via Benzinga
News headline image
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗
Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
News headline image
The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday, 213 companies hit new 52-week lows. 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
News headline image
The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
On Friday, 313 companies hit new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.